Lyell Immunopharma, Inc. (LYEL) stock
LYELNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.67−0.98 (-6.69%)
Close on Nov 17, 2026Market cap $334.98MP/E –Yield –
Lyell Immunopharma ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Lyell Immunopharma's ebitda for the twelve months ending Jun 30, 2026 was -$246.98M. For fiscal 2025 it was -$257.87M. The highest annual figure on record is -$100.83M in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$257.87M | – |
| FY2024 | Dec 31, 2024 | -$339.12M | – |
| FY2023 | Dec 31, 2023 | -$226.76M | – |
| FY2022 | Dec 31, 2022 | -$169.04M | – |
| FY2021 | Dec 31, 2021 | -$201.15M | – |
| FY2020 | Dec 31, 2020 | -$207.64M | – |
| FY2019 | Dec 31, 2019 | -$100.83M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$45.12M | – |
| Q1 FY2026 | Mar 31, 2026 | -$41.93M | – |
| Q4 FY2025 | Dec 31, 2025 | -$125.25M | – |
| Q3 FY2025 | Sep 30, 2025 | -$34.69M | – |
| Q2 FY2025 | Jun 30, 2025 | -$44.01M | – |
| Q1 FY2025 | Mar 31, 2025 | -$53.93M | – |
| Q4 FY2024 | Dec 31, 2024 | -$196.12M | – |
| Q3 FY2024 | Sep 30, 2024 | -$45.83M | – |
| Q2 FY2024 | Jun 30, 2024 | -$46.63M | – |
| Q1 FY2024 | Mar 31, 2024 | -$50.55M | – |
| Q4 FY2023 | Dec 31, 2023 | -$54.45M | – |
| Q3 FY2023 | Sep 30, 2023 | -$53.94M | – |
| Q2 FY2023 | Jun 30, 2023 | -$60.84M | – |
| Q1 FY2023 | Mar 31, 2023 | -$57.53M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.74M | – |
| Q3 FY2022 | Sep 30, 2022 | -$61.82M | – |
| Q2 FY2022 | Jun 30, 2022 | -$33.09M | – |
| Q1 FY2022 | Mar 31, 2022 | -$64.39M | – |
| Q4 FY2021 | Dec 31, 2021 | -$42.97M | – |
| Q3 FY2021 | Sep 30, 2021 | -$45.07M | – |
| Q2 FY2021 | Jun 30, 2021 | -$59.70M | – |
| Q1 FY2021 | Mar 31, 2021 | -$53.41M | – |
| Q4 FY2020 | Dec 31, 2020 | -$38.07M | – |
| Q3 FY2020 | Sep 30, 2020 | -$35.74M | – |
See a number that looks wrong?